Schonfeld Strategic Advisors LLC - KITE PHARMA INC ownership

KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of KITE PHARMA INC
ValueSharesWeighting
Q1 2017$2,430,000
+325.6%
30,966
+171.3%
0.24%
+90.6%
Q2 2016$571,00011,4130.13%
Other shareholders
KITE PHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,358,084$135,991,00055.96%
Lamond Capital Partners LLC 365,900$21,101,00013.82%
EcoR1 Capital, LLC 438,400$25,283,00012.80%
DSAM Partners (London) Ltd 399,571$23,043,0006.08%
Silver Rock Financial LLC 476,563$27,483,0005.08%
Cormorant Asset Management, LP 255,000$14,706,0002.27%
Opaleye Management Inc. 76,000$4,383,0002.22%
Ghost Tree Capital, LLC 60,000$3,460,0001.66%
SPHERA FUNDS MANAGEMENT LTD. 110,970$6,400,0001.09%
PURA VIDA INVESTMENTS, LLC 44,250$2,552,0000.94%
View complete list of KITE PHARMA INC shareholders